<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="brief-report" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">752281</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2021.752281</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>From the Discovery of Extremozymes to an Enzymatic Product: Roadmap Based on Their Applications</article-title>
<alt-title alt-title-type="left-running-head">Espina et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Roadmap to an Extremozyme Product</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Espina</surname>
<given-names>Giannina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/552234/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mu&#xf1;oz-Ibacache</surname>
<given-names>Sebasti&#xe1;n A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1429225/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>C&#xe1;ceres-Moreno</surname>
<given-names>Paulina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1584635/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amenabar</surname>
<given-names>Maximiliano J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/177112/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Blamey</surname>
<given-names>Jenny M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/201435/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Fundaci&#xf3;n Biociencia</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Facultad de Qu&#xed;mica y Biolog&#xed;a, Universidad de Santiago de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/945705/overview">Andres R. Alcantara</ext-link>, Complutense University of Madrid, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/395436/overview">Francesca Paradisi</ext-link>, University of Bern, Switzerland</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/47257/overview">Anastassios C. Papageorgiou</ext-link>, University of Turku, Finland</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/139886/overview">Jennifer Ann Littlechild</ext-link>, University of Exeter, United&#x20;Kingdom</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Giannina Espina, <email>gespina@bioscience.cl</email>; Jenny M. Blamey, <email>jblamey@bioscience.cl</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Industrial Biotechnology, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>752281</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Espina, Mu&#xf1;oz-Ibacache, C&#xe1;ceres-Moreno, Amenabar and Blamey.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Espina, Mu&#xf1;oz-Ibacache, C&#xe1;ceres-Moreno, Amenabar and Blamey</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>With the advent of the industrial revolution, the use of toxic compounds has grown exponentially, leading to a considerable pollution of the environment. Consequently, the development of more environmentally conscious technologies is an urgent need. Industrial biocatalysis appears as one potential solution, where a higher demand for more robust enzymes aims to replace toxic chemical catalysts. To date, most of the commercially available enzymes are of mesophilic origin, displaying optimal activity in narrow ranges of temperature and pH (i.e.,&#x20;between 20&#xb0;C and 45&#xb0;C, neutral pH), limiting their actual application under industrial reaction settings, where they usually underperform, requiring larger quantities to compensate loss of activity. In order to obtain novel biocatalysts better suited for industrial conditions, an efficient solution is to take advantage of nature by searching and discovering enzymes from extremophiles. These microorganisms and their macromolecules have already adapted to thrive in environments that present extreme physicochemical conditions. Hence, extremophilic enzymes stand out for showing higher activity, stability, and robustness than their mesophilic counterparts, being able to carry out reactions at nonstandard conditions. In this brief research report we describe three examples to illustrate a stepwise strategy for the development and production of commercial extremozymes, including a catalase from an Antarctic psychrotolerant microorganism, a laccase from a thermoalkaliphilic bacterium isolated from a hot spring and an amine-transaminase from a thermophilic bacterium isolated from a geothermal site in Antarctica. We will also explore some of their interesting biotechnological applications and comparisons with commercial enzymes.</p>
</abstract>
<kwd-group>
<kwd>biocatalysts</kwd>
<kwd>extremophiles</kwd>
<kwd>catalase</kwd>
<kwd>laccase</kwd>
<kwd>amine-transaminase</kwd>
<kwd>Antarctica</kwd>
</kwd-group>
<contract-sponsor id="cn001">Fondo de Fomento al Desarrollo Cient&#xed;fico y Tecnol&#xf3;gico<named-content content-type="fundref-id">10.13039/501100008736</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Comisi&#xf3;n Nacional de Investigaci&#xf3;n Cient&#xed;fica y Tecnol&#xf3;gica<named-content content-type="fundref-id">10.13039/501100002848</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Corporaci&#xf3;n de Fomento de la Producci&#xf3;n<named-content content-type="fundref-id">10.13039/100009465</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">Air Force Office of Scientific Research<named-content content-type="fundref-id">10.13039/100000181</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The development of the biotechnology industry and the interest for greener and environmentally friendly technologies has led to an increasing demand for more efficient and less contaminant catalysts. Consequently, the global enzymes market has grown from US$2 billion in 2004 (<xref ref-type="bibr" rid="B12">Joseph et&#x20;al., 2008</xref>), to $8.63 billion in 2019, and is expected to reach $14.5 billion by 2027 (<xref ref-type="bibr" rid="B18">Manjrekar and Wadekar, 2021</xref>). However, one of the main problems of using biocatalysts in industrial applications are the harsh conditions at which industrial processes usually take place. Under these settings, mesophilic enzymes that are currently the great majority of commercially available biocatalysts, perform poorly and require larger quantities to compensate for the loss of activity. Therefore, there is a great interest for more stable and efficient biocatalysts, better suited to work optimally at these extreme conditions (<xref ref-type="bibr" rid="B1">Atalah et&#x20;al., 2019</xref>). This can be addressed <italic>via</italic> protein engineering of mesophilic enzymes, combining rational and computational design with directed evolution, to achieve the selectivity, catalytic efficiency and stability required for their industrial use, or by taking advantage of what is already available in Nature.</p>
<p>Extremophilic microorganisms and their macromolecules have already adapted to thrive in environments that present extreme physicochemical conditions. Extremozymes have adapted to optimally perform at, or close to the environmental conditions where extremophilic microorganisms inhabit (e.g., high or low temperatures, acidic or alkaline pH, high pressure, salinity, radiation) (<xref ref-type="bibr" rid="B3">Brininger et&#x20;al., 2018</xref>). These novel extreme biocatalysts with increased stability to denaturing conditions, stand out for being highly efficient, showing higher activity, and robustness than their mesophilic counterparts, being able to carry out reactions at nonstandard conditions, producing low amounts of by-products under a wide range of extreme industrial settings (<xref ref-type="bibr" rid="B11">Gomes and Steiner, 2004</xref>; <xref ref-type="bibr" rid="B4">C&#xe1;ceres-Moreno et&#x20;al., 2019</xref>).</p>
<p>To date, there are two main approaches to discover novel extremozymes from environmental samples. On one hand, due to the inherent difficulty and specific requirements of <italic>in&#x20;vitro</italic> culturing of extremophilic microorganisms, especially archaea, there is a culture independent approach, which is based on metagenomic sequencing followed by data mining to search for specific genes that potentially codify for an enzyme of interest (<xref ref-type="bibr" rid="B37">Sysoev et&#x20;al., 2021</xref>). However, one disadvantage of this strategy is that to date, there is a lack of reliable functional annotation of extremophile genomic data, caused by the low amount of experimentally described genes. This translates in a shortfall of specific databases, with many genes getting annotated as hypothetical proteins with unknown functions, contributing to the problem of information shortage.</p>
<p>On the other hand, there is a culture dependent functional approach that allows to obtain native extremozymes able to catalyze reactions of interest at the desired conditions. For this, extremophiles are grown and isolated under the required selective pressures and then, enzymatic activity-based screening are performed to select the most promising ones for further studies.</p>
<p>After finding novel industrially relevant extremozymes by any of these two approaches, it is necessary to produce them in high amounts to obtain a commercial enzyme product that could be useful for biotechnological applications. Therefore, it is required to develop the recombinant version of the native enzyme of interest by cloning and expressing its coding gene in a suitable heterologous host-vector system, which allows to obtain higher productivity in shorter periods of time. Then, the recombinant extremophilic enzyme functionally overexpressed needs to be biochemically characterized. Finally, it is necessary to perform growth optimization for quality-controlled scale-up and downstream processing (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Strategy for the screening and production of new extreme biocatalysts from environmental samples. Culture dependent and independent approaches to discover novel extremozymes are depicted in the discovery phase.</p>
</caption>
<graphic xlink:href="fbioe-09-752281-g001.tif"/>
</fig>
<p>Here we describe a stepwise strategy based on the culture dependent functional approach, for the discovery, development, scale-up and production of three novel industrially relevant extremozyme products for the Research Market: a catalase, a laccase and an amine transaminase. The experimental work was carried out at Fundacion Biociencia, a Chilean non-profit scientific research institution, with over 20&#xa0;years of experience dedicated to the study of extremophilic microorganisms and their bio-compounds.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Phase 1: Discovery of Extremophiles with Industrially Relevant Enzyme Activities</title>
<p>Environmental samples collected during different Scientific Expeditions to extreme sites are selected according to physicochemical characteristics required for a specific industrial process. Considering the nature of the samples and their original conditions, they are inoculated in different culture media applying specific selection pressures to enrich the culture with microorganisms with the desired characteristics. To this end, because of the growing demand for highly active catalases, microorganisms naturally exposed to environmental stresses that trigger the generation of reactive oxygen species (i.e.,&#x20;low temperatures, high UV radiation) were selected and functionally screened, since they must have an important antioxidant defense mechanism (such as an active catalase) to deal with those extreme conditions. Similarly, because thermostable and thermoactive laccases and amine-transaminases are currently largely required by several industries, thermophilic microorganisms from different extreme environments were selected and functionally screened for these enzyme activities.<list list-type="simple">
<list-item>
<p>- Psychrotolerant catalase producing microorganisms were screened in environmental samples collected from Elephant Island, Antarctica. Samples were cultivated at 8&#xb0;C and pH 6.5 for up to 2&#xa0;weeks. Then, cultures were exposed to UV-C radiation in a specially designed dark chamber for 2&#xa0;h, to enrich microorganisms with better antioxidant defense mechanisms (Monsalves et&#x20;al., 2020).</p>
</list-item>
<list-item>
<p>- Thermoalkaliphilic laccase producing microorganisms were searched in environmental samples collected from a geothermal site and cultivated at 50&#xb0;C, pH 8.0 in media supplemented with lignin as an inductor of laccase activity. Then, functional screening was performed using agar plates containing 0.5&#xa0;mM guaiacol for easy identification of laccase positive brown colored colonies (<xref ref-type="bibr" rid="B33">Sheikhi et&#x20;al., 2012</xref>).</p>
</list-item>
<list-item>
<p>- Thermophilic amine-transaminase producing microorganisms were screened in environmental samples collected from fumaroles located in Whalers Bay, Deception Island, Antarctica. Samples were cultivated at 50&#xb0;C and pH 7.6 for 24&#xa0;h in media supplemented with 10&#xa0;mM <italic>&#x3b1;</italic>-methylbenzylamine (MBA) as an inductor of amine-transaminase activity (<xref ref-type="bibr" rid="B19">M&#xe1;rquez and Blamey, 2019</xref>).</p>
</list-item>
</list>
</p>
<p>Extremophiles that were able to grow under the determined conditions were isolated through several rounds of serial dilutions to extinction, in conjunction with spread-plate techniques until a single morphotype was observed. Isolated strains were maintained by routinely sub-culturing in fresh growth medium and as 20% glycerol suspension stored at &#x2212;80&#xb0;C. Subsequently, a polyphasic approach was used to identify the isolated microorganisms (<xref ref-type="bibr" rid="B28">Ramasamy et&#x20;al., 2014</xref>). In addition, whole genome sequencing of the most promising extremophiles was performed on Illumina Miseq platform using Nextera XT DNA libraries at Georgia Genomics Facility (Georgia, United&#x20;States). The sequenced genomes were assembled, curated and annotated at Fundacion Biociencia. Then, identification of the catalase, laccase and amine-transaminase encoding genes was done through comprehensive bioinformatic analysis of the genome sequence of each selected extremophilic microorganism.</p>
</sec>
<sec id="s2-2">
<title>Phase 2: Development of the Recombinant Versions of Native Extremozymes</title>
<p>Cloning, overexpression and downstream processing is somehow different for every protein. As general considerations, when aiming to develop an enzyme product, selecting an unpatented expression vector/host is relevant in order to prevent infringement of intellectual property. Similarly, the utilization of affinity tags for easier purification, or fusion partners for increased solubility, is not recommended due to their use is often licensed for commercial purposes. Furthermore, selection of the cell location for heterologous expression, needs to consider the culture volumen and the laboratory equipment available, either for cell disruption and fractionation, in the case of intracellular overexpression, or for supernatant concentration when extracellular. For recombinant expression in the well-known, mesophilic heterologous host <italic>Escherichia&#x20;coli</italic>, catalase and laccase encoding genes were PCR-amplified from their native microorganism&#x2019;s genomic DNA using specific oligonucleotide primers, while amine-transaminase was codon optimized and synthesized by Atum (California, United&#x20;States) (<xref ref-type="bibr" rid="B20">M&#xe1;rquez and Blamey, 2019</xref>; <xref ref-type="bibr" rid="B8">Espina et&#x20;al., 2021b</xref>). Then, they were cloned into expression vectors characterized for carrying IPTG-inducible T5 promoter and kanamycin antibiotic resistance gene for selection, with neither affinity tags nor signal peptide for extracellular secretion.</p>
<p>
<italic>E.&#x20;coli</italic> competent cells were chemically transformed with each expression vector carrying the sequence verified genes. The selected transformants were grown aerobically at 37&#x00B0;C, with shaking at 180&#xa0;rpm until OD600 &#x3d; 0.6&#x2013;0.8, in 50&#xa0;ml LB medium supplemented with 30&#xa0;&#x3bc;g/ml kanamycin, plus 2&#xa0;mM CuSO<sub>4</sub> in the case of laccase. At this point, the heterologous expression of the recombinant enzymes was induced by the addition of 0.1&#x2013;0.5&#xa0;mM IPTG and the cultures were further incubated at 30&#xb0;C for 6&#x2013;12&#xa0;h. The cells were harvested by centrifugation at 9000&#xa0;g for 15&#xa0;min at 4&#xb0;C and resuspended in 5&#xa0;ml lysis buffer. Then, cell disruption was carried out by ten 15&#xa0;s bursts of sonication (Branson Sonifier 450), and the cell lysate was centrifuged at 14000&#xa0;g for 30&#xa0;min at 4&#xb0;C in order to obtain the soluble crude extract. Extremozyme&#x2019;s overexpression was evaluated by SDS-PAGE (<xref ref-type="bibr" rid="B10">Gallagher and Sasse, 1998</xref>) and specific enzyme assays:<list list-type="simple">
<list-item>
<p>- Catalase activity was measured spectrophotometrically by monitoring the decrease in absorbance at 240&#xa0;nm, due to the transformation of H<sub>2</sub>O<sub>2</sub> to H<sub>2</sub>O and O<sub>2</sub>. The reaction mixture for the standard assay contained 10&#xa0;mM H<sub>2</sub>O<sub>2</sub> and 50&#xa0;mM potassium phosphate pH 7.0, in a total volume of 3&#xa0;ml. One unit of catalase activity was defined as the decomposition of 1&#xa0;&#xb5;mol of H<sub>2</sub>O<sub>2</sub> per minute (<xref ref-type="bibr" rid="B2">Beers and Sizer, 1952</xref>).</p>
</list-item>
<list-item>
<p>- Laccase activity was assayed spectrophotometrically following the oxidation of syringaldazine substrate to tetramethoxy-azo-bis-methylene-quinone (II) at 530&#xa0;nm. The reaction mixture for the standard assay contained 0.216&#xa0;mM syringaldazine and 100&#xa0;mM potassium phosphate buffer pH 6.0 in a total volume of 3&#xa0;ml. One unit of laccase activity was defined as a change in absorbance at 530&#xa0;nm of 0.001 per minute, under the assay conditions (<xref ref-type="bibr" rid="B15">Lante et&#x20;al., 2000</xref>).</p>
</list-item>
<list-item>
<p>- Amine-transaminase activity toward (S)-<italic>&#x3b1;</italic>-MBA was measured spectrophotometrically following the acetophenone formation at 245&#xa0;nm (<italic>&#x3b5;</italic> &#x3d; 12&#xa0;mM<sup>&#x2212;1</sup>&#xa0;cm<sup>&#x2212;1</sup>) The reaction mixture for the standard assay contained 1&#xa0;mM (S)-<italic>&#x3b1;</italic> methylbenzylamine, 1&#xa0;mM pyruvate and 10&#xa0;&#x3bc;M PLP and 100&#xa0;mM Tris-HCl buffer, pH 8.0 in a total volume of 1&#xa0;ml. One unit of amine-transaminase activity was defined as the amount of enzyme that catalyzed the formation of 1&#xa0;&#x3bc;mol acetophenone from (S)-<italic>&#x3b1;</italic>-MBA and pyruvate in 1&#xa0;min (<xref ref-type="bibr" rid="B32">Sch&#xe4;tzle et&#x20;al., 2009</xref>).</p>
</list-item>
</list>
</p>
<p>Protein concentration was measured by Bradford method, using a commercially assay kit (Bio-Rad, California, United&#x20;States).</p>
<p>The recombinant catalase, laccase and amine-transaminase overexpressed in functional, soluble form with no affinity tags were purified by anion exchange chromatography at room temperature on an &#xc4;KTA Pure FPLC system (GE Healthcare). The soluble crude extracts were diluted 10-fold in loading buffer and loaded onto a pre-equilibrated 25&#xa0;ml Q-sepharose XK 16/20 column. The column was washed with 10&#xa0;column volumes (CV) of the same buffer, followed by a linear NaCl gradient (0&#x2013;1&#xa0;M) for protein elution.</p>
<p>Studies on the pH and temperature dependence were made for each purified recombinant protein in order to biochemically characterize them in terms of optimum pH, optimum temperature and thermostability.</p>
</sec>
<sec id="s2-3">
<title>Phase 3: Optimization and Scale-up of the Biomass and Protein</title>
<p>After obtaining the recombinant extremozymes of interest overexpressed in functional and soluble form, it was necessary to optimize its production at laboratory scale in order to obtain better biomass and protein yields for downstream analyses. This optimization process was done in 250&#xa0;ml flasks and also in a 5L Biostat B-plus bioreactor (Sartorius). The most common parameters to optimize in order to ensure satisfactory levels of biomass and protein overexpression during the production of recombinant extremozymes are: Culture media, pH, growth temperature, agitation rate, aeration, inoculum volume, optimum fermentation volume, culture time, antibiotic concentration, as well as inductor concentration, time, and temperature of induction (<xref ref-type="bibr" rid="B35">Steinberg and Bursztyn, 2010</xref>; <xref ref-type="bibr" rid="B7">Espina et&#x20;al., 2020</xref>).</p>
<p>To determine the optimal parameters, statistical tools such as Analysis of Variance (ANOVA) were used to assess if there were significant differences between the studied factors. In addition, the complementary methodologies: Design of Experiments (DoE) (<xref ref-type="bibr" rid="B17">Mandenius and Brundin, 2008</xref>) and Response Surface Methodology (RSM) (<xref ref-type="bibr" rid="B24">Myers and Montgomery, 2016</xref>), were used to avoid experimental biases and reduce the number of experiments needed to achieve optimal conditions. DoE was used to obtain a matrix of experiments that allow varying more than one variable at the same time, and RSM allowed the analysis of the results obtained from the designed matrix, enabling the study of how the interactions between the input variables influence the output responses. Statgraphics Software (Virginia, United&#x20;States) was used to determine the DoE and to analyze the surface of response using the biomass yield and enzyme activity in order to find the optimal conditions for each of the different enzymes. The combination of the parameters that allow to achieve the highest yield of biomass and recombinant enzyme were successfully determined for catalase and laccase, while for the amine-transaminase these experiments are currently ongoing. When using DoE and RSM methods, the obtained data are evaluated and analyzed to determine if there are significant differences between them and thus, validate if the method was successfully optimized or not. All analyses were carried out using a confidence interval of 95%, which allows to observe significant differences between biomass production, an indicator of a successful optimization.</p>
<p>After the process was optimized for catalase and laccase expression using bench scale reactors, the cultures were then scaled-up in order to replicate the behavior and results obtained in laboratory scale. Usually this increase corresponds to a volume ratio of 1/10 for a consecutive scaled-up (<xref ref-type="bibr" rid="B38">Votruba and Sobotka, 1992</xref>). Also, it is important to maintain the same conditions determined during the optimization and to use bioreactors that maintain geometrical similarity, and constant relations in their dimensions and lengths. The scale-up was considered to be completed when the yield of biomass and enzymes was similar in different scales and this was reproducible.</p>
<p>Then, the scaled-up cells were harvested by centrifugation at 9000&#xa0;g, and disrupted using a high-pressure homogenizer (Constant Systems Cell Disruptor). The crude extract was obtained after ultracentrifugation at 30000&#xa0;g for 20&#xa0;min at 4&#xb0;C. Due to their extremophilic origin an thermal stability, the intracellularly overexpressed catalase and laccase were purified using a heat shock process first, optimized in time and temperature using multifactorial ANOVA. This first purification step allows efficient separation from many native <italic>E. coli</italic> proteins that precipitate with increased temperatures. Then, anion exchange chromatography was used as a second step of purification following the protocol previously described, using a 450&#xa0;ml Q-sepharose resin in XK 50/60 column. It is important to mention that the final purity required for a commercial extremozyme product is directly related to its target applications.</p>
<p>Stability studies of the purified recombinant proteins were made by assaying enzyme activity in time, at two different storage temperatures: 4&#xb0;C and &#x2212;20&#xb0;C. These experiments were made for each protein in solution and also as lyophilized powder as this format could offer easier transportation and sometimes better stability than liquid format.</p>
</sec>
<sec id="s2-4">
<title>Phase 4: Obtaining the Enzyme Product</title>
<p>Achieving reproducibility in each batch in relation to biomass and/or protein production is very important, as the whole process must be validated to ensure that it will consistently generate a product meeting its predetermined specifications. Hence, after successful scale-up, it was necessary to determine and assess quality control points (QCP) in order to obtain a final product with a reproducible quality (<xref ref-type="bibr" rid="B25">Nummer et al., 2015</xref>; <xref ref-type="table" rid="T1">Table&#x20;1</xref>). If the final product complies with the Quality Control Certificate parameters and Product Datasheet specifications, it is labeled and delivered with all the necessary paperwork (e.g., Analysis Certificate, Material Safety Data Sheet and Certificate of Origin) to a final user or an appropriate distributor for its commercialization (<xref ref-type="bibr" rid="B7">Espina et&#x20;al., 2020</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Quality control points (QCP) defined for enzyme production.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Quality control points</th>
<th align="center">Step</th>
<th align="center">Control point</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">QCP1</td>
<td align="left">Seed culture preparation</td>
<td align="left">Control of biomass growth from lab-scale bioreactor (wet biomass yield, g/L)</td>
</tr>
<tr>
<td align="left">QCP2</td>
<td align="left">Biomass production</td>
<td align="left">Control of biomass growth from a larger bioreactor (wet biomass yield, g/L)</td>
</tr>
<tr>
<td align="left">QCP3</td>
<td align="left">Protein extract</td>
<td align="left">Control of enzyme activity (U/ml) and protein concentration (mg/ml) of the extract prior purification</td>
</tr>
<tr>
<td align="left">QCP4</td>
<td align="left">Protein purification</td>
<td align="left">Control of specific activity (U/mg) of the purified protein</td>
</tr>
<tr>
<td align="left">QCP5</td>
<td align="left">Final product processing</td>
<td align="left">Control of specific activity (U/mg) and protein concentration (mg/ml) of the final product</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-5">
<title>Comparison with other Commercial Enzymes</title>
<p>The lyophilized commercial product enz_cat_004 (Swissaustral) was compared with other commercial enzymes: catalase from <italic>Aspergillus niger</italic> (Sigma C3515) and catalase from bovine liver (Sigma C40). Each enzyme was assayed as described above, at different temperatures, between 20&#xb0;C and 70&#xb0;C, at their optimum pH reported by each manufacturer in their data sheets.</p>
<p>The lyophilized commercial product enz_lac_005 (Swissaustral) was compared with other commercial enzymes: Laccase from <italic>Aspergillus sp.</italic> (Sigma SAE0050), laccase from <italic>Aspergillus oryzea</italic> (Novozym 51003) and laccase from <italic>Trametes versicolor</italic> (Sigma 38429). Each enzyme was assayed at different temperatures, between 20&#xb0;C and 80&#xb0;C, at their optimum pH reported by each manufacturer in their data sheets.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Catalase</title>
<p>Catalases (EC 1.11.1.6) are enzymes that act on hydrogen peroxide as an acceptor, characterized by utilizing a second H<sub>2</sub>O<sub>2</sub> molecule as the electron donor, to catalyze its dismutation into H<sub>2</sub>O and O<sub>2</sub> without consuming cellular reducing equivalents (Heck et&#x20;al., 2010). These enzymes have various biotechnological applications as hydrogen peroxide is extensively used as a powerful oxidizing, bleaching, or sterilizing agent by many industries, including food, textile, pulp and paper, biomedicine, clinical diagnostic, bioremediation (<xref ref-type="bibr" rid="B16">Lon&#x10d;ar and Fraaije, 2015</xref>; <xref ref-type="bibr" rid="B6">Espina et&#x20;al., 2021a</xref>).</p>
<p>After functional screening, a psychrotolerant and radiation resistant bacterium was isolated from environmental samples collected from Elephant Island, Antarctica. This microorganism was identified as <italic>Serratia</italic> sp. I1P, with optimal growth conditions at 22&#xb0;C, pH 7.0&#x2013;9.0, 2&#x2013;6% NaCl (<xref ref-type="bibr" rid="B23">Monsalves et&#x20;al., 2020</xref>)<italic>.</italic> A novel catalase was purified from the crude extract and biochemically characterized. The native enzyme was active in a wide range of temperatures (20&#x2013;70&#xb0;C), showing optimal activity at 50&#xb0;C and pH 7.0, with a half-life of 7&#xa0;h when incubated at 50&#xb0;C, which is remarkable considering its psychrotolerant origin (<xref ref-type="bibr" rid="B23">Monsalves et&#x20;al., 2020</xref>).</p>
<p>Optimization of the recombinant overexpression of this enzyme showed that the best growth conditions were REC-P culture medium, at 23&#xb0;C, pH 7.0, 15% pO<sub>2</sub> concentration and 16&#xa0;h cultivation. The optimal culture medium and physico-chemical conditions were determined during the optimization phase done in 5L Biostat B-plus bioreactor, and then scale-up was done in pilot scale using a 40L Biostat C-plus bioreactor (Sartorius).</p>
<p>A comparison of the results of biomass yield, enzymatic yield, and specific activity obtained during each step of the catalase product development is presented in <xref ref-type="table" rid="T2">Table&#x20;2</xref>. The optimized and scale-up recombinant expression allow to raise up the values of activity over 6 times, biomass production increase fivefold and enzyme production over 50&#x20;times.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Comparison of native and recombinant enzyme production.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">
<italic>Serratia</italic> sp. I1P catalase</th>
<th align="center">
<italic>Bacillus</italic> sp. FNT laccase</th>
<th align="center">
<italic>Albidovulum</italic> sp. SLM16&#x20;amine-transaminase</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<bold>Biomass Yield</bold>
</td>
</tr>
<tr>
<td align="left">Native biomass (5L Biostat-B Bioreactor)</td>
<td align="center">5&#xa0;g/L</td>
<td align="center">10&#xa0;g/L spore, 16&#xa0;g/L biomass</td>
<td align="center">8&#xa0;g/L</td>
</tr>
<tr>
<td align="left">Recombinant biomass (5L Biostat-B Bioreactor)</td>
<td align="center">5&#xa0;g/L</td>
<td align="center">20&#xa0;g/L</td>
<td align="center">30&#xa0;g/L</td>
</tr>
<tr>
<td align="left">Optimized recombinant biomass (5L Biostat-B Bioreactor)</td>
<td align="center">16&#xa0;g/L</td>
<td align="center">25&#xa0;g/L</td>
<td align="center">Ongoing experiments</td>
</tr>
<tr>
<td align="left">Scaled-up recombinant biomass (40L Biostat-C Bioreactor)</td>
<td align="center">25&#xa0;g/L</td>
<td align="center">25&#xa0;g/L</td>
<td align="center">Ongoing experiments</td>
</tr>
<tr>
<td align="left">
<bold>Enzymatic Yield</bold>
</td>
</tr>
<tr>
<td align="left">Native enzymatic yield (5L Biostat-B Bioreactor)</td>
<td align="center">8.5&#xa0;mg protein/L culture</td>
<td align="center">4.4&#xa0;mg protein/L culture</td>
<td align="center">12&#xa0;mg protein/L culture</td>
</tr>
<tr>
<td align="left">Recombinant enzymatic yield (5L Biostat-B Bioreactor)</td>
<td align="center">100&#xa0;mg protein/L culture</td>
<td align="center">200&#xa0;mg protein/L culture</td>
<td align="center">28&#xa0;mg protein/L culture</td>
</tr>
<tr>
<td align="left">Optimized recombinant enzymatic Yield (5L Biostat-B Bioreactor)</td>
<td align="center">550&#xa0;mg protein L culture</td>
<td align="center">500&#xa0;mg protein/L culture</td>
<td align="center">Ongoing experiments</td>
</tr>
<tr>
<td align="left">Scaled-up recombinant enzymatic Yield (40L Biostat-C Bioreactor)</td>
<td align="center">443.7&#xa0;mg protein/L culture</td>
<td align="center">450&#xa0;mg protein/L culture</td>
<td align="center">Ongoing experiments</td>
</tr>
<tr>
<td align="left">
<bold>Specific Activity</bold>
</td>
</tr>
<tr>
<td align="left">Native specific activity (5L Biostat-B Bioreactor)</td>
<td align="center">1301&#xa0;U/mg</td>
<td align="center">1000&#xa0;U/mg</td>
<td align="center">0.52&#xa0;U/mg</td>
</tr>
<tr>
<td align="left">Recombinant specific activity (5L Biostat-B Bioreactor)</td>
<td align="center">4000&#xa0;U/mg</td>
<td align="center">200000&#xa0;U/mg</td>
<td align="center">6&#xa0;U/mg</td>
</tr>
<tr>
<td align="left">Optimized specific activity (5L Biostat-B Bioreactor)</td>
<td align="center">10000&#xa0;U/mg</td>
<td align="center">400000&#xa0;U/mg</td>
<td align="center">Ongoing experiments</td>
</tr>
<tr>
<td align="left">Scaled-up specific activity (40L Biostat-C Bioreactor)</td>
<td align="center">&#x2265;8600&#xa0;U/mg</td>
<td align="center">&#x2265;300000&#xa0;U/mg</td>
<td align="center">Ongoing experiments</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The quality control system was applied in every step of the process, which allows to obtain a final enzymatic product with constant reproducibility. Furthermore, stability tests performed showed that at 4&#xb0;C, the liquid enzyme product maintained more than 60% of its activity after 260&#xa0;days and more than 80% of its activity after 320&#xa0;days when stored at &#x2212;20&#xb0;C. The lyophilized enzyme kept the reported activity (&#x3e;8000 U/mg) at least 2&#xa0;years, stored at &#x2212;20&#xb0;C.</p>
<p>This novel thermostable catalase from psychrotolerant origin is currently commercially available as an enzyme product from Swissaustral LLC. Currently, it is available in two formats: liquid (enz_cat_001) and lyophilized (enz_cat_004) with &#x2265;65000&#xa0;U/ml and &#x2265;8000&#xa0;U/mg, respectively.</p>
<p>The comparison of the lyophilized product (enz_cat_004) with two other commercial catalases from fungal and bovine origin (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>), proved that the catalase enzyme, discovered, and developed at Fundacion Biociencia is highly active in a broad range of temperatures (20&#xb0;C&#x2014;70&#xb0;C). This novel extremozyme product is a promising candidate for potential biotechnological applications, as it is better suited than mesophilic enzymes to resist the harsh conditions found in many industrial processes. Unfortunately, commercial catalases as most enzymatic products available on the market, do not report information regarding their purity that could allow further comparisons between products. The catalase product from Swissaustral is currently commercialized at a purity of at least 53% (<xref ref-type="table" rid="T1">Supplementary Table S1</xref>) for biotechnological applications. Additionally, its purity level could be increased up to 95% if required for a specific application, such as biomedical and clinical diagnostic.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Comparison of commercial catalases <bold>(A)</bold> and laccases <bold>(B)</bold> at different temperatures. Each commercial enzyme was assayed at their optimum pH, as reported by each manufacturer in their data sheets. The enzyme assays used were described in the method section for each enzyme. One unit (U) of CAT activity was defined as the decomposition of 1&#xa0;&#xb5;mol of H<sub>2</sub>O<sub>2</sub> per minute. One unit (U) of laccase activity was defined as a change in absorbance at 530&#xa0;nm of 0.001 per minute, under the assay conditions. Error bars indicate standard deviation of triplicate measurements.</p>
</caption>
<graphic xlink:href="fbioe-09-752281-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Laccase</title>
<p>Laccases (EC 1.10.3.2), are enzymes that catalyze the oxidation of a wide array of phenolic and non-phenolic compounds, only requiring oxygen as co-substrate and releasing water as the sole by-product (<xref ref-type="bibr" rid="B29">Riva, 2006</xref>). Due to their broad substrate range, versatility and ease of use, laccases have great biotechnological potential and are useful in many applications such as: Food industry (<xref ref-type="bibr" rid="B27">Osma et&#x20;al., 2010</xref>), pulp and paper (<xref ref-type="bibr" rid="B34">Singh and Arya, 2019</xref>), organic synthesis (<xref ref-type="bibr" rid="B21">Mogharabi and Faramarzi, 2014</xref>), bioremediation (<xref ref-type="bibr" rid="B36">Strong and Claus, 2011</xref>), biofuels (<xref ref-type="bibr" rid="B14">Kudanga and Le Roes-Hill, 2014</xref>), textile industry (<xref ref-type="bibr" rid="B30">Rodr&#xed;guez Couto and Toca Herrera, 2006</xref>), biomedical and pharmaceuticals (<xref ref-type="bibr" rid="B22">Mohit et&#x20;al., 2020</xref>), and biosensors (<xref ref-type="bibr" rid="B5">Castrovilli et&#x20;al., 2019</xref>).</p>
<p>After functional screening, a thermoalkaliphilic spore-forming bacterium was isolated from an environmental sample obtained from a hot spring in a geothermal site. This microorganism was identified as <italic>Bacillus</italic> sp. FNT, with optimal growth conditions at 50&#xb0;C, pH 8.0. A novel laccase was found in the spores, and it was successfully purified and biochemically characterized. The recombinant version of this enzyme exhibits remarkably high specific activity at 70&#xb0;C, pH 6.0, and is active in a wide range of temperature (20&#x2013;90&#xb0;C) with a half-life of 3&#xa0;h when incubated at 60&#xb0;C (<xref ref-type="bibr" rid="B6">Espina et&#x20;al., 2021a</xref>).</p>
<p>Optimization of the recombinant overexpression, showed that the best growth conditions were TBA culture medium supplemented with 2&#xa0;mM CuSO<sub>4</sub>, at 30&#xb0;C, pH 7.0, 15% of pO<sub>2</sub> concentration and 23&#xa0;h cultivation. The optimal culture medium and physico-chemical conditions were determined during the optimization phase done in 5L Biostat B-plus bioreactor, and then scale-up was done in pilot scale using a 40L Biostat C-plus bioreactor.</p>
<p>A comparison of the results of biomass yield, enzymatic yield and specific activity obtained during each step of the laccase product development is presented in <xref ref-type="table" rid="T2">Table&#x20;2</xref>. The optimized and scale-up recombinant expression raise up the values of activity over 300 times, biomass production increase 2.5&#x20;times and enzyme production over hundredfold.</p>
<p>The quality control system was applied in every step of the process, which allows to obtain a final enzymatic product with constant reproducibility. Furthermore, stability tests performed showed that the lyophilized enzyme product maintained the same reported activity at least for 11&#xa0;months at &#x2212;20&#xb0;C. This novel thermostable laccase from thermoalkaliphilic origin is currently commercially available as an enzyme product from Swissaustral LLC. At the moment, it is available only in lyophilized format (enz_lac_005) with &#x2265;300000&#xa0;U/mg. Stability tests of liquid format are currently under evaluation.</p>
<p>The comparison of the product (enz_lac_005) with three other commercial laccases from fungal origin available in the market (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>), proved that the laccase enzyme discovered and developed at Fundacion Biociencia is highly active in a broad range of temperatures, confirming that this novel extremozyme product is a promising candidate for potential biotechnological applications. Swissaustral laccase is currently commercialized at a purity of at least 78% (<xref ref-type="sec" rid="s10">Supplementary Table&#x20;S1</xref>).</p>
</sec>
<sec id="s3-3">
<title>Amine-transaminase</title>
<p>Transaminases (EC 2.6.1. X), are a large pyridoxal 5&#x2019;-phosphate dependent group of enzymes capable of catalyzing the stereoselective reversible transfer of an amino group from a donor substrate to the carbonyl carbon atom of an acceptor substrate (<xref ref-type="bibr" rid="B9">Ferrandi and Monti, 2018</xref>). Amine-transaminases (ATA) are a subgroup of <italic>&#x3c9;</italic>-transaminases enzymes with the ability to perform reductive amination on prochiral ketones using a wide range of primary amine donors and acceptors. Consequently, these enzymes are of great industrial interest especially for the pharmaceutical, fine chemicals and agrochemical industries, since they are a promising alternative to replace the enantioselective chemical synthesis of optically pure chiral amines, which is currently done using transition metals as catalysts (<xref ref-type="bibr" rid="B9">Ferrandi and Monti, 2018</xref>; <xref ref-type="bibr" rid="B13">Kelly et&#x20;al., 2020</xref>).</p>
<p>After functional screening of transaminase activity, a thermophilic bacterium was isolated from an environmental sample collected from coastal fumaroles emerging at the shore at&#x20;Whalers Bay in Deception Island, Antarctica. This microorganism was identified as <italic>Albidovulum</italic> sp. SLM16, with optimal growth conditions at 55&#xb0;C, pH 6.5&#x2013;8.0, 1&#x2013;3% NaCl (<xref ref-type="bibr" rid="B19">M&#xe1;rquez and Blamey, 2019</xref>). A novel (S)-ATA enzyme was purified from the crude extract and biochemically characterized. The recombinant version of this enzyme has been obtained with a purity of 99.7% (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>), and found to be active in a wide range of temperatures (20&#x2013;70&#xb0;C), showing optimal activity at 65&#xb0;C and pH 9.5, with a remarkable thermostability maintaining 80% of its specific activity after 5&#xa0;days of incubation at 50&#xb0;C (<xref ref-type="bibr" rid="B19">Marquez and Blamey, 2019</xref>).</p>
<p>The optimal culture medium for this enzyme overexpression was determined to be TBA. Further optimization of the growth conditions for recombinant overexpression of this enzyme is currently ongoing for subsequent scale-up.</p>
<p>A comparison of the results of biomass yield, enzymatic yield and specific activity obtained during the ATA development is presented in <xref ref-type="table" rid="T2">Table&#x20;2</xref>. The non-optimized recombinant expression raises up the values of activity over 11 times, biomass production increases over 3.5&#x20;times and doubles the enzyme production. These are very promising results indicating that there is still room for improvement after optimization leading to scale-up of enzyme production. The quality control system has to be applied in every step of the process in order to obtain the final enzymatic product with constant reproducibility. Then, stability tests at different storage temperatures in time, and comparison with another commercial ATA will also be performed before obtaining the final enzyme product.</p>
<p>To date, advances are being consistently made in order to develop this industrially relevant, thermophilic and highly thermostable ATA, as a commercial extremozyme product in the near future.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>In the increasing need to replace toxic chemical catalysis for biocatalysis, enzymes derived from microorganisms isolated from extreme environments have called the attention. Their remarkable properties allow them to carry out reactions under nonstandard conditions, being highly suitable for industry. Consequently, the search and discovery of novel enzymes will drive future biotechnological innovation improving current industrial processes.</p>
<p>Even though culture independent bioprospection based on metagenomic sequencing and analysis might help to obtain novel enzyme products in a faster way, many times when interesting encoding genes are selected directly from the genome sequence, there is a risk that they would not necessarily display the desired activity when heterologously overexpressed. Undoubtedly, one of the main advantages of the classic functional approach is that it ensures that there is actually an enzyme with the desired characteristics being functionally expressed in the native microorganism. This increases the probability of producing a recombinant version of the enzyme that keeps similar characteristics to the native one. As presented in this brief research report, using a stepwise strategy based on a culture dependent functional approach, has successfully led to the development of interesting extremozyme commercial products from environmental samples.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>GE: Methodology, Investigation, Formal analysis, Writing original draft, Writing&#x2014;Review and Editing, Funding acquisition; SM-I: Methodology, Investigation, Validation, Formal analysis, Writing&#x2014;Review and Editing; PC-M: Conceptualization, Writing&#x2014;Review and Editing; MA: Writing&#x2014;Review and Editing, Funding acquisition; JB: Conceptualization, Resources, Writing&#x2014;Review and Editing, Funding acquisition.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was supported by the projects: CONICYT FONDEF/CONCURSO IDeA I&#x2b;D, FONDEF/CONICYT 2020 ID20I10055, CONICYT PCI NSFC190024, CORFO INNOVA N&#xb0;15IPPID-45682, AFOSR FA9550-09-1-0349 and Fundacion Cientifica y Cultural Biociencia.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors gratefully acknowledge the logistic support of the Chilean Antarctic Institute (INACH) and the valuable technical assistance of Ms. Valeska Vergara, Ms. Scarlette Carlsson and Mr. Guillermo Mej&#xed;as-Navarrete.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.752281/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2021.752281/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.DOCX" id="SM1" mimetype="application/DOCX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atalah</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>C&#xe1;ceres-Moreno</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Espina</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Blamey</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Thermophiles and the Applications of Their Enzymes as New Biocatalysts</article-title>. <source>Bioresour. Technology</source> <volume>280</volume>, <fpage>478</fpage>&#x2013;<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/j.biortech.2019.02.008</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beers</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>Sizer</surname>
<given-names>I. W.</given-names>
</name>
</person-group> (<year>1952</year>). <article-title>A Spectrophotometric Method for Measuring the Breakdown of Hydrogen Peroxide by Catalase</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>195</volume>, <fpage>133</fpage>&#x2013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(19)50881-x</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brininger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Spradlin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cobani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Evilia</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The More Adaptive to Change, the More Likely You Are to Survive: Protein Adaptation in Extremophiles</article-title>. <source>Semin. Cel Developmental Biol.</source> <volume>84</volume>, <fpage>158</fpage>&#x2013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2017.12.016</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>C&#xe1;ceres-Moreno</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mu&#xf1;oz-Ibacache</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Monsalves</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Amenabar</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Blamey</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2019</year>). &#x201c;<article-title>Functional Approach for the Development and Production of Novel Extreme Biocatalysts</article-title>,&#x201d; in <source>Next Generation Biomanufacturing Technologies</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Rathinam</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Sani</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Chemical Society (ACS) Publications</publisher-name>), <fpage>1</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1021/bk-2019-1329.ch001</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castrovilli</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Bolognesi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chiarinelli</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Avaldi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Antonacci</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The Convergence of Forefront Technologies in the Design of Laccase-Based Biosensors - an Update</article-title>. <source>Trac Trends Anal. Chem.</source> <volume>119</volume>, <fpage>115615</fpage>. <pub-id pub-id-type="doi">10.1016/j.trac.2019.07.026</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Espina</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Atalah</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Blamey</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>Extremophilic Oxidoreductases for the Industry: Five Successful Examples with Promising Projections</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>9</volume>, <fpage>710035</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2021.710035</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Espina</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>C&#xe1;ceres-Moreno</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Correa-Llant&#xe9;n</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sarmiento</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Blamey</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2020</year>). &#x201c;<article-title>4 Extremozymes: from Discovery to Novel Bio-Products</article-title>,&#x201d; in <source>Biotechnological Applications of Extremophilic Microorganisms</source>. Editor <person-group person-group-type="editor">
<name>
<surname>Lee</surname>
<given-names>N. M.</given-names>
</name>
</person-group> (<publisher-loc>Ume&#xe5;</publisher-loc>: <publisher-name>De Gruyter</publisher-name>), <fpage>97</fpage>&#x2013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1515/9783110424331-004</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Espina</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>C&#xe1;ceres-Moreno</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mej&#xed;as-Navarrete</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Blamey</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>A Novel and Highly Active Recombinant Spore-Coat Bacterial Laccase, Able to Rapidly Biodecolorize Azo, Triarylmethane and Anthraquinonic Dyestuffs</article-title>. <source>Int. J.&#x20;Biol. Macromolecules</source> <volume>170</volume>, <fpage>298</fpage>&#x2013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.12.123</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrandi</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Monti</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Amine Transaminases in Chiral Amines Synthesis: Recent Advances and Challenges</article-title>. <source>World J.&#x20;Microbiol. Biotechnol.</source> <volume>34</volume>, <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1007/s11274-017-2395-2</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallagher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sasse</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Protein Analysis by SDS&#x2010;PAGE and Detection by Coomassie Blue or Silver Staining</article-title>. <source>Curr. Protoc. Pharmacol.</source> <volume>2</volume>, <fpage>3B</fpage>. <pub-id pub-id-type="doi">10.1002/0471141755.pha03bs02</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The Biocatalytic Potential of Extremophiles and Extremozymes</article-title>. <source>Food Technol. Biotechnol.</source> <volume>42</volume>, <fpage>223</fpage>&#x2013;<lpage>235</lpage>. </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joseph</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ramteke</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Cold Active Microbial Lipases: Some Hot Issues and Recent Developments</article-title>. <source>Biotechnol. Adv.</source> <volume>26</volume>, <fpage>457</fpage>&#x2013;<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2008.05.003</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Mix</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moody</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Gilmore</surname>
<given-names>B. F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Transaminases for Industrial Biocatalysis: Novel Enzyme Discovery</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>104</volume>, <fpage>4781</fpage>&#x2013;<lpage>4794</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-020-10585-0</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kudanga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Le Roes-Hill</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Laccase Applications in Biofuels Production: Current Status and Future Prospects</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>98</volume>, <fpage>6525</fpage>&#x2013;<lpage>6542</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-014-5810-8</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lante</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Crapisi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krastanov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Spettoli</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Biodegradation of Phenols by Laccase Immobilised in a Membrane Reactor</article-title>. <source>Process Biochem.</source> <volume>36</volume>, <fpage>51</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/S0032-9592(00)00180-1</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lon&#x10d;ar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fraaije</surname>
<given-names>M. W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Catalases as Biocatalysts in Technical Applications: Current State and Perspectives</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>99</volume>, <fpage>3351</fpage>&#x2013;<lpage>3357</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-015-6512-6</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandenius</surname>
<given-names>C.-F.</given-names>
</name>
<name>
<surname>Brundin</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Bioprocess Optimization Using Design-Of-Experiments Methodology</article-title>. <source>Biotechnol. Prog.</source> <volume>24</volume>, <fpage>1191</fpage>&#x2013;<lpage>1203</lpage>. <pub-id pub-id-type="doi">10.1002/btpr.67</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Manjrekar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wadekar</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2021</year>). <source>Enzymes Market Type (Protease, Carbohydrase, Lipase, Polymerase and Nuclease, and Other Types), Source (Microorganisms, Plants, and Animals), Reaction Type (Hydrolase, Oxidoreductase, Transferase, Lyase, and Other Reaction Types), and Application (Food and Beverages, Household Care, Bioenergy, Pharmaceutical and Biotechnology, Feed, and Other Applications) - Global Opportunity Analysis and Industry Forecast</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.alliedmarketresearch.com/enzymes-market">https://www.alliedmarketresearch.com/enzymes-market</ext-link> (Accessed June 15, 2021)</comment>. </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xe1;rquez</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Blamey</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Characterization of a Novel Thermostable (S)-amine-transaminase from an Antarctic Moderately-Thermophilic Bacterium <italic>Albidovulum</italic> Sp. SLM16</article-title>. <source>Enzyme Microb. Technology</source> <volume>131</volume>, <fpage>109423</fpage>. <pub-id pub-id-type="doi">10.1016/j.enzmictec.2019.109423</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xe1;rquez</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Blamey</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Isolation and Partial Characterization of a New Moderate Thermophilic <italic>Albidovulum</italic> Sp. SLM16 with Transaminase Activity from Deception Island, Antarctica</article-title>. <source>Biol. Res.</source> <volume>52</volume>, <fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/s40659-018-0210-7</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mogharabi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Faramarzi</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Laccase and Laccase-Mediated Systems in the Synthesis of Organic Compounds</article-title>. <source>Adv. Synth. Catal.</source> <volume>356</volume>, <fpage>897</fpage>&#x2013;<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201300960</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohit</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tabarzad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Faramarzi</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Biomedical and Pharmaceutical-Related Applications of Laccases</article-title>. <source>Cpps</source> <volume>21</volume>, <fpage>78</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.2174/1389203720666191011105624</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monsalves</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Ollivet-Besson</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Amenabar</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Blamey</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Isolation of a Psychrotolerant and UV-C-Resistant Bacterium from Elephant Island, Antarctica with a Highly Thermoactive and Thermostable Catalase</article-title>. <source>Microorganisms</source> <volume>8</volume>, <fpage>95</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms8010095</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Myers</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>D. C.</given-names>
</name>
</person-group> (<year>2016</year>). <source>Response Surface Methodology: Process and Product Optimization Using Designed Experiments</source>. <edition>4th ed.</edition> <publisher-loc>New York, NY, USA</publisher-loc>: <publisher-name>John Wiley &#x26; Sons</publisher-name>. </citation>
</ref>
<ref id="B25">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Nummer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gump</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Montalbano</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <source>Regulatory Foundations for the Food Protection Professional. Regulatory Foundations for the Food Protection Professional</source>. <publisher-loc>New York, US</publisher-loc>: <publisher-name>Springer</publisher-name>. </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osma</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<name>
<surname>Toca-Herrera</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Couto</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Uses of Laccases in the Food Industry</article-title>. <source>Enzyme Res.</source> <volume>2010</volume>, <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4061/2010/918761</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramasamy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Lagier</surname>
<given-names>J.-C.</given-names>
</name>
<name>
<surname>Padhmanabhan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sentausa</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>A Polyphasic Strategy Incorporating Genomic Data for the Taxonomic Description of Novel Bacterial Species</article-title>. <source>Int. J.&#x20;Syst. Evol. Microbiol.</source> <volume>64</volume>, <fpage>384</fpage>&#x2013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1099/ijs.0.057091-0</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riva</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Laccases: Blue Enzymes for green Chemistry</article-title>. <source>Trends Biotechnol.</source> <volume>24</volume>, <fpage>219</fpage>&#x2013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2006.03.006S</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez Couto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Toca Herrera</surname>
<given-names>J.&#x20;L.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Industrial and Biotechnological Applications of Laccases: A Review</article-title>. <source>Biotechnol. Adv.</source> <volume>24</volume>, <fpage>500</fpage>&#x2013;<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2006.04.003</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sch&#xe4;tzle</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>H&#xf6;hne</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Redestad</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Robins</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bornscheuer</surname>
<given-names>U. T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Rapid and Sensitive Kinetic Assay for Characterization of &#x3c9;-Transaminases</article-title>. <source>Anal. Chem.</source> <volume>81</volume>, <fpage>8244</fpage>&#x2013;<lpage>8248</lpage>. <pub-id pub-id-type="doi">10.1021/ac901640q</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheikhi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>RoayaeiArdakani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Enayatizamir</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rodriguez-Couto</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The Determination of Assay for Laccase of <italic>Bacillus Subtilis</italic> WPI with Two Classes of Chemical Compounds as Substrates</article-title>. <source>Indian J.&#x20;Microbiol.</source> <volume>52</volume>, <fpage>701</fpage>&#x2013;<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1007/s12088-012-0298-3</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arya</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Utility of Laccase in Pulp and Paper Industry: A Progressive Step towards the green Technology</article-title>. <source>Int. J.&#x20;Biol. Macromolecules</source> <volume>134</volume>, <fpage>1070</fpage>&#x2013;<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.05.168</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinberg</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Bursztyn</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Response Surface Methodology in Biotechnology</article-title>. <source>Qual. Eng.</source> <volume>22</volume>, <fpage>78</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1080/08982110903510388</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strong</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Claus</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Laccase: A Review of its Past and its Future in Bioremediation</article-title>. <source>Crit. Rev. Environ. Sci. Technology</source> <volume>41</volume>, <fpage>373</fpage>&#x2013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1080/10643380902945706</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sysoev</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gr&#xf6;tzinger</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Renn</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Eppinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rueping</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Karan</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Bioprospecting of Novel Extremozymes from Prokaryotes-The Advent of Culture-independent Methods</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>, <fpage>630013</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.630013</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Votruba</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sobotka</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Physiological Similarity and Bioreactor Scale-Up</article-title>. <source>Folia Microbiol.</source> <volume>37</volume>, <fpage>331</fpage>&#x2013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1007/bf02815659</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>